Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
Christina M. Surawicz, MD
Professor Emeritus
Biography

Dr. Surawicz is a gastroenterologist who has been practicing general GI at Harborview Medical Center since 1981. She was section chief until 2013. She has been a leader in treating patients with recurrent C. difficile infection with fecal microbiota transplantation.

Recent Publications
Displaying 20 Most Recent Publications from PubMed

October 2018. The Do's and Don'ts of Social Media: A Guide For Gastroenterologists. Bilal M, Taleban S, Riegler J, Surawicz C, Feld A. Am J Gastroenterol. 2018 Oct 17. doi: 10.1038/s41395-018-0369-0. [Epub ahead of print]

April 2018. Managing Clostridium difficile: an old bug with new tricks. Vindigni SM, Surawicz CM. Am J Gastroenterol. 2018 Apr 24. doi: 10.1038/s41395-018-0059-y. [Epub ahead of print]

September 2017. How I Approach It: Strategies to Combat Physician Burnout in Gastroenterology. Anderson JC, Pfeil S, Surawicz C. Am J Gastroenterol. 2017 Sep;112(9):1356-1359. doi: 10.1038/ajg.2017.251. Epub 2017 Aug 8.

March 2017. Fecal Microbiota Transplantation. Vindigni SM, Surawicz CM. Gastroenterol Clin North Am. 2017 Mar;46(1):171-185. doi: 10.1016/j.gtc.2016.09.012.

December 2016. Women in Leadership: Why So Few and What to Do About It. Surawicz CM. J Am Coll Radiol. 2016 Dec;13(12 Pt A):1433-1437. doi: 10.1016/j.jacr.2016.08.026. Epub 2016 Oct 27.

June 2016. Stool transplant for the senior citizen: Is it safe? Vindigni SM, Surawicz CM. Maturitas. 2016 Jun;88:23-4. doi: 10.1016/j.maturitas.2016.03.006. Epub 2016 Mar 7.

May 2016. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals. Agrawal M, Aroniadis OC, Brandt LJ, Kelly C, Freeman S, Surawicz C, Broussard E, Stollman N, Giovanelli A, Smith B, Yen E, Trivedi A, Hubble L, Kao D, Borody T, Finlayson S, Ray A, Smith R. J Clin Gastroenterol. 2016 May-Jun;50(5):403-7. doi: 10.1097/MCG.0000000000000410.

May 2016. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience. Aroniadis OC, Brandt LJ, Greenberg A, Borody T, Kelly CR, Mellow M, Surawicz C, Cagle L, Neshatian L, Stollman N, Giovanelli A, Ray A, Smith R. J Clin Gastroenterol. 2016 May-Jun;50(5):398-402. doi: 10.1097/MCG.0000000000000374.

October 2015. Cirrhosis and C. difficile: A Deadly Duo? Vindigni SM, Surawicz CM. Dig Dis Sci. 2015 Oct;60(10):2865-7. doi: 10.1007/s10620-015-3777-7.

October 2015. Fecal microbiota transplantation: current clinical efficacy and future prospects. Bowman KA, Broussard EK, Surawicz CM. Clin Exp Gastroenterol. 2015 Oct 23;8:285-91. doi: 10.2147/CEG.S61305. eCollection 2015. Review.

July 2015. C. difficile Infection: Changing Epidemiology and Management Paradigms. Vindigni SM, Surawicz CM. Clin Transl Gastroenterol. 2015 Jul 9;6:e99. doi: 10.1038/ctg.2015.24.

July 2015. The gut microbiome: a clinically significant player in transplantation? Vindigni SM, Surawicz CM. Expert Rev Clin Immunol. 2015 Jul;11(7):781-3. doi: 10.1586/1744666X.2015.1043894. Epub 2015 Jun 11.

May 2015. Fecal microbiota transplantation: what we know and what we need to know. Surawicz CM. Ann Intern Med. 2015 May 5;162(9):662-3. doi: 10.7326/M15-0609.

March 2015. Clostridium Difficile Infection: Risk Factors, Diagnosis and Management. Surawicz CM. Curr Treat Options Gastroenterol. 2015 Mar;13(1):121-9. doi: 10.1007/s11938-014-0038-3.

October 2014. Response to gorbach et Al. Curry S, Surawicz C, Binion D, Brandt L. Am J Gastroenterol. 2014 Oct;109(10):1684-5. doi: 10.1038/ajg.2014.229. No abstract available.

August 2014. Infectious diarrhea: an overview. Dickinson B, Surawicz CM. Curr Gastroenterol Rep. 2014 Aug;16(8):399. doi: 10.1007/s11894-014-0399-8.

July 2014. Burnout in gastroenterologists and how to prevent it. Keswani RN, Keefer L, Surawicz CM. Gastroenterology. 2014 Jul;147(1):11-4. doi: 10.1053/j.gastro.2014.05.023. Epub 2014 May 23.

July 2014. Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients. Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, Aroniadis O, Barto A, Borody T, Giovanelli A, Gordon S, Gluck M, Hohmann EL, Kao D, Kao JY, McQuillen D, Mellow M, Rank KM, Rao K, Ray A, Schwartz MA, Singh N, Stollman N, Suskind DL, Vindigni SM, Youngster I, Brandt L. Am J Gastroenterol. 2014 Jul;109(7):1065-71. doi: 10.1038/ajg.2014.133. Epub 2014 Jun 3.

April 2014. J. Edward berk distinguished lecture: avoiding burnout: finding balance between work and everything else. Surawicz CM. Am J Gastroenterol. 2014 Apr;109(4):511-4. doi: 10.1038/ajg.2014.44. Epub 2014 Mar 18.

February 2014. Clostridium difficile infection in the elderly. Keller JM, Surawicz CM. Clin Geriatr Med. 2014 Feb;30(1):79-93. doi: 10.1016/j.cger.2013.10.008.

January 2014. Gastro 2013 APDW/WCOG Shanghai Working Party Report Chronic Diarrhea: Definition, Classification, Diagnosis. Schiller LR, Pardi DS, Spiller R, Semrad CE, Surawicz CM, Giannella RA, Krejs GJ, Farthing MJ, Sellin JH. J Gastroenterol Hepatol. 2014 Jan;29(1):6-25. doi: 10.1111/jgh.12392.

September 2013. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Vindigni SM, Broussard EK, Surawicz CM. Expert Rev Gastroenterol Hepatol. 2013 Sep;7(7):615-28. doi: 10.1586/17474124.2013.832501.

September 2013. Fecal microbiota transplantation and donor standardization. Owens C, Broussard E, Surawicz C. Trends Microbiol. 2013 Sep;21(9):443-5. doi: 10.1016/j.tim.2013.07.003.

September 2013. Management of the Elderly Patients with Inflammatory Bowel Disease: Practical Considerations. Katz S, Surawicz C, Pardi DS. Inflamm Bowel Dis. 2013 Sep;19(10):2257-72. doi: 10.1097/MIB.0b013e31828c8536.

July 2013. Clostridium difficile Infection. Knight CL, Surawicz CM. Med Clin North Am. 2013 Jul;97(4):523-36. doi: 10.1016/j.mcna.2013.02.003. Epub 2013 Apr 24.

April 2013. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Am J Gastroenterol. 2013 Apr;108(4):478-98. doi: 10.1038/ajg.2013.4. Epub 2013 Feb 26.

January 2013. Infection: Treating recurrent C. difficile infection-the challenge continues. Surawicz CM. Nat Rev Gastroenterol Hepatol. 2013 Jan;10(1):10-1. doi: 10.1038/nrgastro.2012.240. Epub 2012 Dec 4.

October 2012. Infectious causes of chronic diarrhoea. Kaiser L, Surawicz CM. Best Pract Res Clin Gastroenterol. 2012 Oct;26(5):563-71. doi: 10.1016/j.bpg.2012.11.001.

October 2012. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Damman CJ, Miller SI, Surawicz CM, Zisman TL. Am J Gastroenterol. 2012 Oct;107(10):1452-9. doi: 10.1038/ajg.2012.93.

July 2012. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, Stollman N, Rohlke F, Surawicz C. Am J Gastroenterol. 2012 Jul;107(7):1079-87. doi: 10.1038/ajg.2012.60. Epub 2012 Mar 27.

Contact Info
Education

M.D., University of Kentucky College of Medicine, Lexington, KY

Residency in Medicine, University of Washington, Seattle, WA

Fellowship in Gastroenterology, University of Washington, Seattle, WA

©2016-2018 University of Washington Division of Gastroenterology
1959 NE Pacific St., Box 356424, Seattle, WA 98195-6424
Contact Us | Privacy | Terms | Copyright & Disclaimer